Literature DB >> 22846385

Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data.

E R C Millett1, D Noel, P Mangtani, I Abubakar, M E Kruijshaar.   

Abstract

Completion of treatment is key to tuberculosis control. Using national surveillance data we assessed factors associated with tuberculosis patients being lost to follow-up before completing treatment ('lost'). Patients reported in England, Wales and Northern Ireland between 2001 and 2007 who were lost 12 months after beginning treatment were compared to those who completed, or were still on treatment, using univariable and multivariable logistic regression. Of 41 120 patients, men [adjusted odds ratio (aOR) 1·29; 95% confidence interval (CI) 1·23-1·35], 15- to 44-year-olds (P<0·001), and patients with pulmonary sputum smear-positive disease (aOR 1·25, 95% CI 1·12-1·45) were at higher risk of being lost. Those recently arrived in the UK were also at increased risk, particularly those of the White ethnic group (aOR 6·39, 95% CI 4·46-9·14). Finally, lost patients had a higher risk of drug resistance (aOR 1·41, 95% CI 1·17-1·69). Patients at risk of being lost require enhanced case management and novel case retention methods are needed to prevent this group contributing towards onward transmission.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846385      PMCID: PMC9151834          DOI: 10.1017/S095026881200163X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  11 in total

1.  Revised international definitions in tuberculosis control.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  2001-03       Impact factor: 2.373

2.  Increase in extrapulmonary tuberculosis in England and Wales 1999-2006.

Authors:  M E Kruijshaar; I Abubakar
Journal:  Thorax       Date:  2009-10-22       Impact factor: 9.139

3.  "It is more than the issue of taking tablets": the interplay between migration policies and TB control in Sweden.

Authors:  Asli Kulane; Beth M Ahlberg; Ingela Berggren
Journal:  Health Policy       Date:  2010-03-29       Impact factor: 2.980

4.  Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001.

Authors:  Delphine Antoine; Clare E French; Jane Jones; John M Watson
Journal:  J Epidemiol Community Health       Date:  2007-04       Impact factor: 3.710

5.  Tuberculosis drug resistance in England and Wales. How much is 'home-grown'?

Authors:  A C Hayward; J Herbert; J M Watson
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

Review 6.  Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients.

Authors:  J Veen; M Raviglione; H L Rieder; G B Migliori; P Graf; M Grzemska; R Zalesky
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

7.  Tuberculosis in London: the importance of homelessness, problem drug use and prison.

Authors:  A Story; S Murad; W Roberts; M Verheyen; A C Hayward
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

8.  Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis.

Authors:  Ulf R Dahle; Per Sandven; Einar Heldal; Turid Mannsaaker; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective.

Authors:  I C Ditah; M Reacher; C Palmer; J M Watson; J Innes; M E Kruijshaar; H N Luma; I Abubakar
Journal:  Thorax       Date:  2007-07-05       Impact factor: 9.139

10.  Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation.

Authors:  Mark Jit; Helen R Stagg; Robert W Aldridge; Peter J White; Ibrahim Abubakar
Journal:  BMJ       Date:  2011-09-14
View more
  4 in total

1.  Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.

Authors:  Demelash Woldeyohannes; Yohannes Tekalegn; Biniyam Sahiledengle; Tesfaye Assefa; Rameto Aman; Zeleke Hailemariam; Lillian Mwanri; Alemu Girma
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 2.  Tuberculosis in tropical areas and immigrants.

Authors:  Lorenzo Zammarchi; Filippo Bartalesi; Alessandro Bartoloni
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

3.  Towards better guidance on caseload thresholds to promote positive tuberculosis treatment outcomes: a cohort study.

Authors:  Helen R Stagg; Ibrahim Abubakar; James Brown; Maeve K Lalor; H Lucy Thomas; Tehreem Mohiyuddin; Debora Pedrazzoli; Corinne S Merle
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

4.  Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014.

Authors:  Jean-Paul Guthmann; Lucie Léon; Delphine Antoine; Daniel Lévy-Bruhl
Journal:  Euro Surveill       Date:  2020-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.